Screener
BioCryst Pharmaceuticals BCRX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from BioCryst Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
FAQ
- What is BioCryst Pharmaceuticals's price / sales?
- BioCryst Pharmaceuticals (BCRX) reported price / sales of 2.7× in Q2 2026.
- How has BioCryst Pharmaceuticals's price / sales changed year-over-year?
- BioCryst Pharmaceuticals's price / sales decreased by 27.5% year-over-year, from 3.7× to 2.7×.
- What is the long-term trend for BioCryst Pharmaceuticals's price / sales?
- Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's price / sales has grown at a -52.2% compound annual growth rate (CAGR), from 75.3× to 1.9×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about BioCryst Pharmaceuticals's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude